Joseph S McCracken
CIK 1632454 · last filed 2026-02-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.59M
Companies
4
Total Filings
43
Lifetime Open-Market Net
$531.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SVRA | Director | 302,644 | $5.26 | $1.59M | $428.1K | 15 | 2026-02-17 |
| LUMOS PHARMA, INC. (LUMO) Delisted | Director | 0 | $4.34 | $0 | $103.8K | 9 | 2024-12-13 |
| Kindred Biosciences, Inc. (KIN) Delisted | Director | — | $9.25 | — | $0 | 6 | 2021-08-30 |
| Nexvet Biopharma plc (NVET) Delisted | Director | 12,800 | — | — | $0 | 12 | 2017-07-05 |
Recent Filings · Page 4 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-05 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +4,100 | $512 | EDGAR |
| 2017-06-09 | SVRA | Buy (P) | +52,250 | $248.2K | EDGAR |
| 2017-04-04 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2017-01-03 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2016-10-04 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2016-09-07 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | — | $0 | EDGAR |
| 2016-07-01 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +4,100 | $512 | EDGAR |
| 2016-04-04 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2016-01-05 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2015-10-01 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.